Murine Survivin (97-104)

Murine Survivin (97-104) is a synthetic peptide fragment derived from the C-terminal region of murine Survivin, a member of the inhibitor of apoptosis (IAP) protein family. Recognized for its crucial role in regulating cell division and inhibiting programmed cell death, Survivin is a highly conserved protein implicated in diverse cellular processes and is frequently studied in the context of cancer biology, cell cycle regulation, and apoptosis signaling. The 97-104 peptide sequence represents a specific epitope within the Survivin protein, making it a valuable tool for researchers investigating the molecular mechanisms of cell survival, immune recognition, and protein-protein interactions in murine models.

Epitope mapping: As a defined peptide sequence corresponding to a region of murine Survivin, the 97-104 fragment is frequently utilized in epitope mapping studies. Researchers employ this peptide to delineate antibody binding sites, enabling the characterization of immune responses against Survivin in murine systems. Such studies are essential for understanding the immunogenic properties of Survivin and for the development of peptide-based immunoassays or antibody production protocols targeting this specific protein region.

Immunological assay development: The peptide serves as a standard or antigen for the development and optimization of immunological assays, including enzyme-linked immunosorbent assays (ELISA), immunoblotting, and T cell activation studies. By incorporating the Survivin (97-104) peptide into assay platforms, investigators can quantitatively monitor antigen-specific immune responses, assess antibody specificity, or evaluate T cell recognition in preclinical research settings. This application is particularly relevant in studies exploring the immune landscape of cancer or autoimmunity in murine models.

Peptide-based vaccine research: The defined sequence of the Survivin (97-104) peptide supports its use as a candidate epitope in peptide-based vaccine design and immunogenicity testing. In preclinical research, the peptide is employed to evaluate the efficacy of vaccine constructs or adjuvant formulations aimed at eliciting targeted immune responses against Survivin. Such studies provide critical insights into the mechanisms by which immune tolerance or activation can be modulated in vivo, informing the development of novel immunotherapeutic strategies.

Protein interaction studies: The Survivin (97-104) peptide is a valuable probe for dissecting protein-protein interactions involving the C-terminal domain of Survivin. By serving as a molecular mimic of the native protein region, the peptide allows researchers to investigate binding partners, assess structural determinants of interaction, and elucidate the functional consequences of specific sequence motifs. These studies contribute to a deeper understanding of Survivin's role in cellular signaling networks and the regulation of apoptosis.

Cell signaling and functional analysis: In cellular and biochemical assays, the peptide can be used to interrogate signaling pathways regulated by Survivin or to competitively inhibit endogenous protein interactions. By introducing the 97-104 peptide into cell-based systems, researchers can explore its impact on downstream signaling events, cell cycle progression, or apoptotic processes. Such functional analyses are instrumental in unraveling the complex biology of Survivin and its significance in murine models of disease and development.

1. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency